Recognition and management of complications of new recreational drug use

被引:92
作者
Ricaurte, GA
McCann, UD
机构
[1] Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Dept Neurol, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Dept Psychiat, Baltimore, MD USA
关键词
D O I
10.1016/S0140-6736(05)66737-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Use of illicit drugs in clubs and large dance parties (so-called raves) is a burgeoning cultural trend. Such recreational drug use is associated with several medical complications, both acute and longlasting. Although few, if any, of the drugs currently used in recreational venues are truly new, their patterns and context of use have changed (a great deal in some instances). For some of these substances, this cultural repackaging of the drug experience has resulted in various medical disorders that have previously gone undocumented. This review aims to help treating physicians recognise and manage complications associated with the use of new drugs in clubs, including methylenedioxymethamfetamine, ephedrine, gamma-hydroxybutyrate; gamma-butyrolactone, 1,4-butanediol, flunitrazepam, ketamine, and nitrites. We also alert researchers to specific toxic effects of club-drugs on which more basic information is needed.
引用
收藏
页码:2137 / 2145
页数:9
相关论文
共 56 条
[1]   Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator γ-hydroxybutyrate [J].
Andriamampandry, C ;
Taleb, O ;
Viry, S ;
Muller, C ;
Humbert, JP ;
Gobaille, S ;
Aunis, D ;
Maitre, M .
FASEB JOURNAL, 2003, 17 (10) :1691-+
[2]   Medical progress - Heat stroke [J].
Bouchama, A ;
Knochel, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (25) :1978-1988
[3]   Gamma butyrolactone (GBL) withdrawal syndromes [J].
Catalano, MC ;
Glass, JM ;
Catalano, G ;
Burrows, SL ;
Lynn, WA ;
Weitzner, BS .
PSYCHOSOMATICS, 2001, 42 (01) :83-88
[4]   Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later [J].
Curran, HV ;
Morgan, C .
ADDICTION, 2000, 95 (04) :575-590
[5]   Non-linear pharmacokinetics of MDMA ('ecstasy') in humans [J].
de la Torre, R ;
Farré, M ;
Ortuño, J ;
Mas, M ;
Brenneisen, R ;
Roset, PN ;
Segura, J ;
Camí, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (02) :104-109
[6]  
Diehl JL, 2000, ANN MED INTERNE, V151, pA44
[7]   The many faces of ecstasy [J].
Doyon, S .
CURRENT OPINION IN PEDIATRICS, 2001, 13 (02) :170-176
[8]   Flunitrazepam: an evaluation of use, abuse and toxicity [J].
Druid, H ;
Holmgren, P ;
Ahlner, J .
FORENSIC SCIENCE INTERNATIONAL, 2001, 122 (2-3) :136-141
[9]   Gamma-hydroxybutyrate withdrawal syndrome [J].
Dyer, JE ;
Roth, B ;
Hyma, BA .
ANNALS OF EMERGENCY MEDICINE, 2001, 37 (02) :147-153
[10]  
*EMCDDA, STAT DRUGS PROBL EUR